MedTrace Logo

Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF

NCT02109822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2016-10-26

No results posted yet for this study

Summary

The goal of this research study is to better understand current treatment practices for pulmonary exacerbations (lung infections) and whether the Cystic Fibrosis National Patient Registry (CFFNPR)can be used for this type of study.

Conditions

Sponsors & Collaborators

  • Medical University of South Carolina

    collaborator OTHER

  • Cystic Fibrosis Foundation

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Christopher H. Goss, MD MSc · University of Washington

  • Patrick Flume, MD · Medical University of South Carolina

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02109822 on ClinicalTrials.gov